Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1999
10/05/1999US5962487 Picornaviral 3c protease inhibitors
10/05/1999US5962486 Headache therapy
10/05/1999US5962485 N-(2-benzyloxy-1-phenethyl)-N-(2'-methoxyethyl)amino-methane compounds are useful as tachykinin antagonists
10/05/1999US5962483 Antiasthma agents; antiinflammatory agents
10/05/1999US5962482 Method of reducing cellulite in mamalian skin
10/05/1999US5962480 Containing pyran-4-one or pyrid-4-one ring
10/05/1999US5962479 Psychological and nervous sytem disorders
10/05/1999US5962478 Inhibition of tumor necrosis factor α
10/05/1999US5962477 Screening methods for cytokine inhibitors
10/05/1999US5962475 Osteoporosis, restenosis, breast cancer
10/05/1999US5962474 Analgesics; headaches
10/05/1999US5962473 Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F
10/05/1999US5962472 Alzheimer's, parkinson, huntington diseases; amyotropic laterial sclerosis; nervous system disorders
10/05/1999US5962471 Substituted 6- and 7-aminotetrahydroisoquinolinecarboxylic acids
10/05/1999US5962470 Heterocyclic compounds having anti-diabetic activity and their use
10/05/1999US5962469 Cyclic nitrones
10/05/1999US5962468 Antibacterial activity
10/05/1999US5962467 Derivatives of swainsonine and their use as therapeutic agents
10/05/1999US5962465 Brain disorders; psychological disorders
10/05/1999US5962464 Side effect reduction
10/05/1999US5962463 Methods of stimulating non-amyloidogenic processing of the amyloid precursor protein
10/05/1999US5962462 Spiro-substituted azacycles as modulators of chemokine receptor activity
10/05/1999US5962461 Mixture of polyvinylpyrrolidone, polyol and ammonium glycyrrhizinate
10/05/1999US5962459 Administering animal growth stimulator; uridine
10/05/1999US5962458 Angiogenesis inhibitors, anticancer agents, antidiabetic agents, skin disorders, autoimmune diseases, antiinflammatory agents, vision defects
10/05/1999US5962457 2,3 Disubstituted- (5,6)-heteroarylfused-pyrimidine-4-ones
10/05/1999US5962456 Peptic ulcers
10/05/1999US5962455 Eating disorders, cardiovascular disorders, hypotensive agents
10/05/1999US5962454 Antitumor agents, arteriosclerosis, rheumatic disorders, vision defects, skin disorders
10/05/1999US5962453 Triazine derivative and medicine
10/05/1999US5962451 Gastrointestinal disorders; antiulcer agent; anticancer agents; side-effect reduction
10/05/1999US5962450 Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines and their use as medicaments
10/05/1999US5962449 Analgesics; antiinflammatory agents; non-insulin-dependentdiabetes
10/05/1999US5962447 Psychological disorders, cognition activators, schizophrenia
10/05/1999US5962446 Administering protein kinase inhibitors
10/05/1999US5962445 Treatment of asthma and airway diseases
10/05/1999US5962444 Hormone inhibitor; hormone replacement therapy
10/05/1999US5962443 19-nur-pregnane steroids as neurochemical initiators of change in human hypothalamic function
10/05/1999US5962442 Administering a 3-oxo-4-azasteroid
10/05/1999US5962441 Anti-aging lotion
10/05/1999US5962440 Cyclic phosphonate ester inhibitors of microsomal triglyceride transfer protein and method
10/05/1999US5962439 Cardiovascular disorder
10/05/1999US5962437 Hepatitis, herpes and aida virus
10/05/1999US5962435 Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols
10/05/1999US5962433 Topical composition containing hyaluronic acid and NSAIDS
10/05/1999US5962432 Sterilized, isotonic and pH-adjusted pharmaceutical formulation of uridine triphosphate
10/05/1999US5962431 Method of treating papillomavirus using 2',5'-oligoadenylate
10/05/1999US5962426 Hybrid
10/05/1999US5962422 Inhibition of selectin binding
10/05/1999US5962421 Pharmacological association between N-acetylcysteine and levulose for preventing cellular death and related diseases
10/05/1999US5962419 Nervous system disorders; brain disorders
10/05/1999US5962417 Reducing activation of tyrosinase
10/05/1999US5962413 Dysmenorrhea
10/05/1999US5962411 Human growth hormone variants and methods of administering same
10/05/1999US5962410 Fungicides, antiprotozoa agent
10/05/1999US5962409 Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone
10/05/1999US5962316 Cell-cycle regulatory proteins, and uses related thereto
10/05/1999US5962314 Certain cells in the body respond not only to chemical signals, but also to ions such as extracellular calcium ions (ca.sup.2+). the invention relates to nucleic acids encoding such receptors and cells containing such nucleic acids.
10/05/1999US5962312 Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders
10/05/1999US5962259 Response regulator polynucleotides
10/05/1999US5962230 Diagnosis and treatment of glaucoma
10/05/1999US5962217 MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, and biopolymer constituents thereof
10/05/1999US5962216 Tumor-activated prodrug compounds and treatment
10/05/1999US5962056 Neutralizing the oil with an amount of a saturated aqueous solution of crystalline disodium carbonate equivalent to two to ten times the weight of oleic acid in the oil calculated after assay; separating phases, washing drying
10/05/1999US5962049 Boron carbohydrate complexes and uses thereof
10/05/1999US5962043 Weight reduction method for dogs and other pets
10/05/1999US5962024 Peroral composition for controlled release in the lower gastrointestinal tract
10/05/1999US5962021 Combined pharmaceutical estrogen-androgen-progestin oral contraceptive
10/05/1999US5962019 Alkanol solvent of from 2 to 3 carbon atoms in combination with at least one non-ionic surfactant.
10/05/1999US5962018 Microsphere formed of a non-polar copolymer of a carbamate and an acrylate
10/05/1999US5962013 Monolithic matrix transdermal delivery system for administering molsidomine
10/05/1999US5962012 Cholinergic antagonist patch
10/05/1999US5962010 Methods and compositions for treating dermatoses
10/05/1999US5962008 Topical medicament for use in treatment of anorectal inflammation
10/05/1999US5962000 Vitamin a and an antiinflammatory drug selected from the group consisting of hydrocortisone, acetaminophine, allantoin, glycyrrhetic stearyl, and dermatologically acceptable salts of glycyrrhizic acid.
10/05/1999US5961997 Antipruritic composition
10/05/1999US5961993 Composition containing a non-photocatalytic metal oxide and tocopherol, its use in the treatment of acne
10/05/1999US5961987 Ocular protein stimulants
10/05/1999US5961981 Biologically-active compositions extracted from dictyotales plant family
10/05/1999US5961969 Enhancing natural killer cell cytotoxicity.
10/05/1999US5961483 Iontophoretic delivery of cell adhesion inhibitors
10/05/1999CA2195924C 3-aza and 3-oxa-piperidone tachykinin antagonists
10/05/1999CA2189534C Imidazole derivatives and processes for the preparation thereof
10/05/1999CA2175204C Certain fused pyrrolecarboxanilides; a new class of gaba brain receptor ligands
10/05/1999CA2173544C Use of a least one 6"-substituted pyrimidine derivative in a composition as a cyclooxygenase activator and/or stabilizer
10/05/1999CA2161962C Adenovirus vectors for gene therapy
10/05/1999CA2158147C Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
10/05/1999CA2009902C Heterocycles
10/01/1999CA2249043A1 Novel compounds
10/01/1999CA2227508A1 Paip, a novel human protein which bridges the 3' and 5' end of mrna, and use thereof as a target for translational modulation to treat human disease
09/1999
09/30/1999WO1999049858A1 Utilization of alkyl hydrogen fumerates for treating psoriasis, psoriatic arthritis, neurodermatitis and regional enteritis
09/30/1999WO1999049316A2 Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer
09/30/1999WO1999049055A1 Human casb12 polypeptide, a serine protease
09/30/1999WO1999049033A1 Casb414: antigen overexpressed in several tumors
09/30/1999WO1999049027A1 Methods for prevention and treatment of cancer
09/30/1999WO1999049025A2 Human vault rna
09/30/1999WO1999048916A2 Hypoxia-inducible human genes, proteins, and uses thereof
09/30/1999WO1999048902A1 Azt derivatives exhibiting spermicidal and anti-viral activity
09/30/1999WO1999048901A2 Sucrose-n-alkyl-asparaginates, production and use thereof
09/30/1999WO1999048896A1 Cephalosporines having cyclic aminoguanidine substituents as antibiotics
1 ... 6436 6437 6438 6439 6440 6441 6442 6443 6444 6445 6446 6447 6448 6449 6450 6451 6452 6453 6454 6455 6456 ... 7860